SFES — Safeguard Scientifics Balance Sheet
0.000.00%
- $16.37m
- $6.87m
- 32
- 49
- 77
- 52
Annual balance sheet for Safeguard Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25 | 15.6 | 29.3 | 20.1 | 9.5 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 26.4 | 16.1 | 30.3 | 21.4 | 9.91 |
Net Property, Plant And Equipment | 2.1 | 1.79 | 1.56 | 1.29 | 0.971 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 108 | 69 | 54 | 37.7 | 22.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 2.43 | 3.47 | 1.73 | 1.82 | 2.05 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.84 | 6.16 | 3.46 | 3.12 | 2.86 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 102 | 62.9 | 50.6 | 34.6 | 20 |
Total Liabilities & Shareholders' Equity | 108 | 69 | 54 | 37.7 | 22.8 |
Total Common Shares Outstanding |